Ensign Peak Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $903K | Hold |
6,569
| – | – | ﹤0.01% | 1297 |
|
|
2025
Q1 | $1.18M | Hold |
6,569
| – | – | ﹤0.01% | 1158 |
|
|
2024
Q4 | $1.03M | Hold |
6,569
| – | – | ﹤0.01% | 1303 |
|
|
2024
Q3 | $1.2M | Hold |
6,569
| – | – | ﹤0.01% | 1224 |
|
|
2024
Q2 | $1.21M | Sell |
6,569
-14,348
| -69% | -$2.63M | ﹤0.01% | 1162 |
|
|
2024
Q1 | $3.72M | Buy |
20,917
+14,017
| +203% | +$2.49M | 0.01% | 718 |
|
|
2023
Q4 | $856K | Hold |
6,900
| – | – | ﹤0.01% | 1466 |
|
|
2023
Q3 | $800K | Buy |
6,900
+2,050
| +42% | +$238K | ﹤0.01% | 1362 |
|
|
2023
Q2 | $569K | Buy |
+4,850
| New | +$569K | ﹤0.01% | 1599 |
|
|
2022
Q4 | – | Sell |
-3,670
| Closed | -$256K | – | 2013 |
|
|
2022
Q3 | $256K | Buy |
+3,670
| New | +$256K | ﹤0.01% | 1775 |
|
|
2021
Q4 | – | Sell |
-34,596
| Closed | -$1.81M | – | 2216 |
|
|
2021
Q3 | $1.81M | Buy |
+34,596
| New | +$1.81M | ﹤0.01% | 1185 |
|